SLC7A11 and neoplasm: Moreover, mregDCs are a specific DC subgroup that expresses high amounts of SLC7A11, and the KO of this gene combined with radiofrequency ablation (RFA) therapy resulted in increased tumor regression in a subcutaneous tumor model compared with RFA monotherapy [136].